ZEJULA Logo

GET AN INSIDE LOOK AT ZEJULA

Browse our collection of videos to learn how it may help appropriate patients.

ONCE-DAILY ZEJULA

IS APPROVED FOR FIRST-LINE MAINTENANCE IN ADULTS WITH PLATINUM-RESPONSIVE ADVANCED OVARIAN CANCER REGARDLESS OF BIOMARKER STATUS.1

Learn more about how ZEJULA works and who it may help.

VISIT THE SITE

TOGETHER WITH GSK ONCOLOGY

For information on access and reimbursement services.

STAY IN THE

KNOW

Register for updates on the latest video content.

SIGN UP

GSK Medical Information

If you have medical questions, contact us.

CONTACT US

Reference: 1. ZEJULA (niraparib). Prescribing Information. GlaxoSmithKline; 2021.